Unbiased Analysis of Today's Healthcare Issues
How will HEOR leaders respond to recent policy changes? A survey from Tufts and the Center for the Evaluation of Value and Risk in Health (CEVR) provides the answer. About 2/3 of the n=57 respondents were Head of their HEOR department and the remaining 1/3 had some other senior level HEOR role. Whereas 29.8% of…
That is the title of my guest column at The Evidence Base. An excerpt is below: Multiple indicators suggest that health economics and outcomes research (HEOR) faces unprecedented challenges to its traditional role in pharmaceutical value demonstration. Yet these apparent threats may signal evolution rather than decline – if the field can adapt to serve…
Health economics and outcomes research has already started to use AI tools such as large language models (LLM) across a diverse set of study types, including systematic literature reviews (SLR), health economic modelling (HEM) and real-world evidence (RWE). In SLRs, LLMs can assist with abstract and full-text screening, bias assessment, data extraction, and automating meta-analysis…